We are live on ! Find out more
WINT

Windtree Therapeutics Inc
WINT

Delisted

WINT was delisted on the 4th of May, 2017.

Back to rankings

56 hedge funds and large institutions have $59.1M invested in Windtree Therapeutics Inc in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more call options, than puts

Call options by funds: $427K | Put options by funds: $204K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 62 → 56 (-6)

14% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 14

37% less capital invested

Capital invested by funds: $93.8M → $59.1M (-$34.7M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
56
Holders Change
-6
Holders Change %
-9.68%
% of All Funds
1.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
12
Reduced
14
Closed
13
Calls
$427K
Puts
$204K
Net Calls
+$223K
Net Calls Change
+$263K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$940K
2
TI
Turner Investments
Pennsylvania
+$357K
3
Morgan Stanley
Morgan Stanley
New York
+$345K
4
CS
Credit Suisse
Switzerland
+$160K
5
OAM
Oxford Asset Management
United Kingdom
+$156K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$893K
2
NC
Northpointe Capital
Michigan
-$615K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$256K
4
NIP
Nicholas Investment Partners
California
-$189K
5
Deutsche Bank
Deutsche Bank
Germany
-$144K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$14.8M +$30.8K +1,402 +0.2%
BC
2
Broadfin Capital
New York
$9.36M – – –
DCM
3
DAFNA Capital Management
California
$6.61M – – –
DM
4
Deerfield Management
New York
$4.25M – – –
BBA
5
Baker Bros. Advisors
New York
$4.24M – – –
TI
6
Turner Investments
Pennsylvania
$3.51M +$357K +16,247 +8%
BIT
7
BlackRock Institutional Trust
California
$2.92M +$9.92K +451 +0.3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.67M +$81K +3,686 +2%
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$1.98M -$256K -11,654 -9%
TCM
10
Tamarack Capital Management
California
$1.74M – – –
Millennium Management
11
Millennium Management
New York
$1.54M +$940K +42,736 +82%
Deutsche Bank
12
Deutsche Bank
Germany
$1.44M -$144K -6,561 -7%
Wellington Management Group
13
Wellington Management Group
Massachusetts
$838K -$117K -5,344 -9%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$527K +$1.6K +73 +0.2%
BFA
15
BlackRock Fund Advisors
California
$305K +$29.5K +1,342 +8%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$279K -$103K -4,688 -21%
Morgan Stanley
17
Morgan Stanley
New York
$273K +$345K +15,672 +1,383%
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$234K – – –
Northern Trust
19
Northern Trust
Illinois
$186K – – –
SC
20
Searle & Co
Connecticut
$172K +$233K +10,607 New
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$136K -$100K -4,550 -35%
Goldman Sachs
22
Goldman Sachs
New York
$129K -$42.1K -1,914 -19%
CS
23
Credit Suisse
Switzerland
$118K +$160K +7,289 New
OAM
24
Oxford Asset Management
United Kingdom
$115K +$156K +7,087 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$76K – – –
1
2 3

WINT Hedge Fund Activity: Q4 2014 in Review

56 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q4 2014, worth a combined $59.1M — down 37% from $93.8M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of WINT and 8 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 12 added.

The largest buyer was Millennium Management, adding an estimated $940K. The largest seller was Sphera Funds Management, exiting entirely with an estimated $893K sold.

  • 56 institutional investors held Windtree Therapeutics Inc (WINT) as of Q4 2014, down from 62 in Q3 2014.
  • Funds reported $59.1M of Windtree Therapeutics Inc stock for Q4 2014, down 37% quarter-over-quarter.
  • 8 funds opened new Windtree Therapeutics Inc positions in Q4 2014 and 13 closed out, a net change of -5 holders.
  • The largest Windtree Therapeutics Inc buyer in Q4 2014 was Millennium Management, an estimated $940K added.
  • The largest Windtree Therapeutics Inc seller in Q4 2014 was Sphera Funds Management, an estimated $893K sold.

Based on aggregated 13F filings for Q4 2014.